- Home
- FLGT vs ORIC Comparison
FLGT vs ORIC Comparison
Compare FLGT & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLGT
- ORIC
- Stock Information
- Founded
- FLGT 2011
- ORIC 2014
- Country
- FLGT United States
- ORIC United States
- Employees
- FLGT N/A
- ORIC N/A
- Industry
- FLGT Medical Specialities
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- FLGT Health Care
- ORIC Health Care
- Exchange
- FLGT Nasdaq
- ORIC Nasdaq
- Market Cap
- FLGT 683.5M
- ORIC 633.7M
- IPO Year
- FLGT 2016
- ORIC 2020
- Fundamental
- Price
- FLGT $17.11
- ORIC $9.12
- Analyst Decision
- FLGT Hold
- ORIC Strong Buy
- Analyst Count
- FLGT 2
- ORIC 9
- Target Price
- FLGT $28.50
- ORIC $18.75
- AVG Volume (30 Days)
- FLGT 253.6K
- ORIC 482.7K
- Earning Date
- FLGT 11-08-2024
- ORIC 11-12-2024
- Dividend Yield
- FLGT N/A
- ORIC N/A
- EPS Growth
- FLGT N/A
- ORIC N/A
- EPS
- FLGT N/A
- ORIC N/A
- Revenue
- FLGT $277,761,000.00
- ORIC N/A
- Revenue This Year
- FLGT N/A
- ORIC N/A
- Revenue Next Year
- FLGT $14.04
- ORIC N/A
- P/E Ratio
- FLGT N/A
- ORIC N/A
- Revenue Growth
- FLGT N/A
- ORIC N/A
- 52 Week Low
- FLGT $16.56
- ORIC $6.33
- 52 Week High
- FLGT $30.68
- ORIC $16.65
- Technical
- Relative Strength Index (RSI)
- FLGT 35.11
- ORIC 46.99
- Support Level
- FLGT $16.56
- ORIC $8.11
- Resistance Level
- FLGT $18.61
- ORIC $8.90
- Average True Range (ATR)
- FLGT 1.08
- ORIC 0.74
- MACD
- FLGT -0.33
- ORIC -0.09
- Stochastic Oscillator
- FLGT 12.60
- ORIC 33.78
About FLGT Fulgent Genetics Inc.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.